Diabetic Retinopathy Clinical Trials in Hagerstown, Maryland

3 studies are recruiting for diabetic retinopathy in Hagerstown, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

    Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for ev…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Mid Atlantic Retina ( Site 0062), Hagerstown, Maryland
    Locations
    8 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07705555 on ClinicalTrials.gov

  2. Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

    Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in the back part of the eye (called the retina). Over time, this damage can lead to vision problems and even blindness if not treated. This study will assess surabgene lomp…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Mid Atlantic Retina Specialists - Hagerstown /ID# 274725, Hagerstown, Maryland
    Locations
    33 in total
    Run by
    AbbVie

    See if you can join NCT07592273 on ClinicalTrials.gov

  3. A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01

    The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabetic Retinopathy of Non-Proliferative Type (NPDR). The primary objective of the study is to evaluate the efficacy of daily oral doses of VX-…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Cumberland Valley Retina Consultants, Hagerstown, Maryland
    Locations
    26 in total
    Run by
    Vantage Biosciences Ltd

    See if you can join NCT06770933 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.